Fusidic acid

Generic name
Fusidic acid
Brand name
ATC Code
J01XC01

Fusidic acid

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Bacterial infections
  • Oral
    • < 12 years
      • 25 - 50 mg/kg/day in 3 doses.
      • Duration of treatment:

        At least 6 days

    • 12 years up to 18 years
      • 1.500 mg/day in 3 doses.
      • Duration of treatment:

        At least 6 days

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

In vitro, fusidic acid displaces bilirubin from its binding site on albumin; make allowances for this in premature infants in particular and in neonates who are icteric, have acidosis or are severely ill.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

OTHER ANTIBACTERIALS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Glycopeptide antibacterials
J01XA04
J01XA02
J01XA01
Polymyxins
J01XB01
Nitrofuran derivatives
J01XE01
Other antibacterials
J01XX09
J01XX08
J01XX01

References

  1. Hartwig NC, et al, Vademecum pediatrische antimicrobiële therapie, 2005
  2. Leo Pharma BV, SPC Fucidin (RVG 01369) 22-4-2015, www.geneesmiddeleninformatiebank.nl, Geraadpleegd 28 okt 2016

Changes

Therapeutic Drug Monitoring


Overdose